R. Navarro

Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer

J. Marshall, A. Wellstein, M. Pishvaian, 2013, International Journal of Colorectal Disease.